The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response—a randomized, controlled trial | Zendy

Åsa Magnusson | Zendy; Lars Nilsson | Zendy; Göran Oleröd | Zendy; Ann ThurinKjellberg | Zendy; Christina Bergh | Zendy

Open Access

The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response—a randomized, controlled trial

Author(s) -

Åsa Magnusson,

Lars Nilsson,

Göran Oleröd,

Ann ThurinKjellberg,

Christina Bergh

Publication year - 2017

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dex012

Subject(s) - antral follicle , anti müllerian hormone , medicine , ovarian hyperstimulation syndrome , ovarian reserve , randomized controlled trial , gynecology , controlled ovarian hyperstimulation , live birth , pregnancy rate , regimen , assisted reproductive technology , pregnancy , in vitro fertilisation , obstetrics , hormone , infertility , biology , genetics

Does the addition of anti-Müllerian hormone (AMH) to a conventional dosage regimen, including age, antral follicle count (AFC) and BMI, improve the rate of targeted ovarian response, defined as 5-12 oocytes after IVF?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research